NIH-funded research R01 grant

Investigating how endocrine disrupting chemicals affect male neurobehavioral disorders.

Official title: Endocrine Disrupting Chemicals and Male-biased Neurobehavioral Disorders

Funded at University of Rochester · NIH-10992140 · Data updated 2026-11-12

This study is looking at how everyday chemicals that can disrupt hormones might affect brain development in boys with ADHD and Autism, hoping to find ways to help prevent and treat these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startFebruary 3, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$336,242
NIH project number5R01ES034829-03
Project IDNIH-10992140 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children, particularly males, who are at risk for or diagnosed with neurodevelopmental disorders such as ADHD or Autism Spectrum Disorders.

Less likely to help

Patients who are not male or do not have neurodevelopmental disorders may not receive direct benefits from this research.

What this research studies

This research focuses on understanding the impact of endocrine disrupting chemicals (EDCs) on neurodevelopmental disorders like ADHD and Autism Spectrum Disorders in children. It examines how these chemicals, which are often found in everyday products, may contribute to the male bias observed in these disorders. The study utilizes a curated mixture of EDCs to analyze their effects on testosterone levels and subsequent behavioral changes in male mice, which may mirror similar effects in humans. By identifying the mechanisms behind these disorders, the research aims to provide insights into prevention and treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential interventions for neurodevelopmental disorders in children.

How similar studies have gone: Previous studies have indicated a link between EDC exposure and neurodevelopmental disorders, suggesting that this research builds on established findings rather than exploring an entirely novel approach.

Where this research is happening

  • University of Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Terry, Marissa Sobolewski — University of Rochester
  • Study coordinator: Terry, Marissa Sobolewski

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.